An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries

Sustainable care for children with cancer: a Lancet Oncology Commission

(2020) Rifat Atun et al.   LANCET ONCOLOGY

Radiation Therapy Research: A Global Analysis 2001-2015

(2018) Ajay Aggarwal et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Unknown

(2018)   CA-A CANCER JOURNAL FOR CLINICIANS

Explicit Bias Toward High-Income-Country Research: A Randomized, Blinded, Crossover Experiment Of English Clinicians

(2017) Matthew Harris et al.   HEALTH AFFAIRS

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration

(2017) Ariadna Tibau et al.   JNCI-Journal of the National Cancer Institute

Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks

(2017) Joseph C Del Paggio et al.   LANCET ONCOLOGY

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13

(2017) Courtney Davis et al.   BMJ-British Medical Journal

Availability of evidence of benefits on overall survival and quality of life of cancer drugs approved by European Medicines Agency: retrospective cohort study of drug approvals 2009-13

(2017) Courtney Davis et al.   BMJ-British Medical Journal

Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration

(2017) Ariadna Tibau et al.   JNCI-Journal of the National Cancer Institute

The State of Lung Cancer Research: A Global Analysis

(2016) Ajay Aggarwal et al.   Journal of Thoracic Oncology

Partnerships, Not Parachutists, for Zika Research

(2016) David L. Heymann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial

(2015) Rajendra Badwe et al.   LANCET ONCOLOGY

Elective versus Therapeutic Neck Dissection in Node-Negative Oral Cancer

(2015) Anil K. D’Cruz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Shifting Patterns in the Interpretation of Phase III Clinical Trial Outcomes in Advanced Non–Small-Cell Lung Cancer: The Bar Is Dropping

(2014) Adrian G. Sacher et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of VIA Screening by Primary Health Workers: Randomized Controlled Study in Mumbai, India

(2014) S. S. Shastri et al.   JNCI-Journal of the National Cancer Institute

Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

(2014) Tito Fojo et al.   JAMA Otolaryngology-Head & Neck Surgery

Cancer survival: global surveillance will stimulate health policy and improve equity

(2013) Michel P Coleman   LANCET

Evidence for non-communicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification

(2013) C Heneghan et al.   BMJ Open

Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end points

(2011) A. Kay et al.   ANNALS OF ONCOLOGY

Expansion of cancer care and control in countries of low and middle income: a call to action

(2010) Paul Farmer et al.   LANCET

Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer

(2009) B. Seruga et al.   ANNALS OF ONCOLOGY

Ethical and Scientific Implications of the Globalization of Clinical Research

(2009) Seth W. Glickman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evolution of the Randomized Controlled Trial in Oncology Over Three Decades

(2008) Christopher M. Booth et al.   JOURNAL OF CLINICAL ONCOLOGY